| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |